MedPath

A multicenter randomized controlled trial assessing and comparing long-term scar quality after micrografting versus mesh grafting of deep dermal burns

Conditions
patients with clinically deep burn or deep skin defect between 4% and 20% TBSA
Registration Number
NL-OMON29090
Lead Sponsor
niversity Hospital Ghent, Belgium
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

•Patients =18 years
•Clinically deep burn or deep skin defect between 4% and 20% TBSA
•Patients with two comparable deep partial thickness and/or full thickness burns, confirmed by laser Doppler imaging (LDI) or deep skin defects, of minimum 1:2 plissee = 36cm², requiring surgery after assessment by a (plastic) surgeon/burn physician
•Patients who are mentally capable to give legal consent or legal representative when the patient is temporarily incompetent (e.g. patient is sedated/ventilated)

Exclusion Criteria

•Patient has participated in another study utilizing an investigational drug or device within the previous 30 days
•Wounds covering face, hands or joints
•Patient has one or more medical condition(s) that in the opinion of the treating physician would make the patient an inappropriate candidate for this study
•Patients who are expected (according to the responsible medical doctor) to be non-compliant to the study protocol. (This includes patients with severe cognitive dysfunction/impairment and severe psychiatric disorders).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ong-term scar quality 12 months after skin transplantation assessed with the Patient and Observer Scar Assessment Scale (POSAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath